Antibodies are among the most important protein-detecting reagents in research, yet they can be surprisingly unreliable. It’s an issue close to Alejandra Solache’s heart. “The way many antibodies are ...
For the first time this fall, families will be offered season-long protection for infants and some children against respiratory syncytial virus (RSV). The US Food and Drug Administration (FDA) in July ...
Tulisokibart is a tumor necrosis factor–like cytokine 1A (TL1A) monoclonal antibody in development for the treatment of moderately to severely active ulcerative colitis. A genetic-based diagnostic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback